Self Diagnostics - US

Self Diagnostics - US

An increasing prevalence of diabetes and hypertension in the US population has fueled the robust market for self-diagnostic testing kits, especially those that monitor glucose or blood pressure. Demographic factors, a growing self-care trend, insurance coverage and shifting birth and infertility rates have also played a roll in sales for everything from pregnancy tests to ovulation prediction kits to glucose/blood pressure monitors.

Beyond discussion of these driving trends, this report also analyzes:

• How the mail order/direct-to-consumer services impact the FDM retail market
  
  
• Which drug stores lead the market and how they combat mail order competition
  
  
• Why Johnson & Johnson-owned companies comprise a full quarter of the FDM market, while most other companies have experienced sales declines since 2005
  
  
• How older Americans, women and different ethnic groups offer unique marketing opportunities for self-diagnostic testing kit manufacturers
  
  
• Who uses self-diagnostics, why and how they feel about it
  
  
• How the market will change and develop in coming years

This report builds on the analysis presented in Mintel's Self-Diagnostics—US, March 2004. The self-diagnostics market is defined as any product, device or test that is used by the consumer to identify or monitor a specific health condition without medical or professional assistance. This includes both chemically based home testing kits and electronic devices.

For the purpose of this report, Mintel has included only the following in its market size:

• Blood glucose monitors
  
  
• Blood pressure monitors
  
  
• Home pregnancy tests
  
  
• Ovulation tests.

Excluded from this report are tests carried out by hospitals, doctors, nurses, pharmacists or other healthcare workers. Also excluded are devices such as scales, which are used solely to measure weight, and other physical measuring devices, such as thermometers.  
 

SCOPE AND THEMES

What you need to know

Definition

Abbreviations and terms

Abbreviations

Terms

The Consumer

CPI

EXECUTIVE SUMMARY

Diverse drivers for sales of self-diagnostics

Condition prevalence

Fluctuating birth rates, infertility prevalence

Self-care a growing trend

Insurance coverage

Demographics

Shrinking FDM market due to competition from non-traditional suppliers

Blood glucose monitor, pregnancy test segments anchor market

Supply chain dominated by a handful of manufacturers

Drug stores remain retail destination of choice, but mail order steals share

The consumer

Among ethnic respondents

Market forecast

MARKET DRIVERS AND FUTURE TRENDS

Prevalence of conditions calling for self-monitoring

Key points:

Details

Figure 1: Prevalence of high blood cholesterol, by gender, race and ethnicity, 2001*

Figure 2: percentage of adults who reported having high blood pressure, by gender, race and ethnicity, 2001

and 2005

Figure 3: Percentage of adults who reported having overweight/obesity, by gender, race and ethnicity, 2001 &

2005

Shifting birth rates

Infertility prevalence

Self-care trend grows

Health insurance

Insurance coverage of home diagnostics

Health insurance costs grow more prohibitive

Number of uninsured reaches all-time high

Figure 4: People without health insurance for the entire year, by selected demographics, 2005 and 2006

Demographics

Total population projections

Figure 5: Population by age, 2002-12

Female population

Figure 6: Female population by age, 2002-12

Ethnic population

Figure 7: Population by race and Hispanic origin, 2002-12

MARKET SIZE AND TRENDS

MARKET SIZE

Figure 8: Total U.S. retail sales of home diagnostics, at current and constant prices, 2002-07*

MARKET TRENDS

Glucose monitors

Pregnancy tests

Blood pressure monitors

Ovulation tests

MARKET SEGMENTATION

Self-diagnostics segments

Figure 9: FDM sales of home diagnostics, segmented by type, 2005 and 2007

Glucose monitors

Figure 10: FDM sales of glucose monitors, at current and constant prices, 2002-07

Pregnancy tests

Figure 11: Sales of pregnancy tests, at current and constant prices, 2002-07

Blood pressure monitors

Figure 12: FDM sales of blood pressure monitors, at current and constant prices, 2002-07

Ovulation tests

Figure 13: FDM sales of ovulation tests, at current and constant prices, 2002-07

SUPPLY STRUCTURE

INTRODUCTION

COMPANIES AND BRANDS

Figure 14: Manufacturer FDM sales of home diagnostics in the U.S., 2005 and 2007

Glucose monitors

Figure 15: Manufacturer FDM brand sales of glucose monitors in the U.S., 2005 and 2007

Pregnancy tests

Figure 16: Manufacturer FDM brand sales of pregnancy tests in the U.S., 2005 and 2007

Blood pressure monitors

Figure 17: Manufacturer FDM brand sales of blood pressure monitors in the U.S., 2005 and 2007

Ovulation tests

Figure 18: Manufacturer FDM brand sales of ovulation tests in the U.S., 2005 and 2007

ADVERTISING AND PROMOTION

Direct-to-consumer glucose monitors

Manufacturer activity

LifeScan

Omron Healthcare, Inc.

Inverness Medical, Inc

Roche Diagnostics

Bayer

RETAIL DISTRIBUTION

Introduction

Figure 20: U.S. FDM retail sales of home diagnostics, by channel, 2005 and 2007

Drug stores

Figure 21: U.S. FDM drug store sales of home diagnostics, at current and constant prices, 2002-07

Mass merchandisers

Figure 22: U.S. FDM mass merchandiser sales of home diagnostics, at current and constant prices, 2002-07

Supermarkets

Figure 23: U.S. FDM supermarket sales of home diagnostics, at current and constant prices, 2002-07

Mail order/direct-to-consumer

THE CONSUMER

Summary

Among ethnic respondents

USAGE AND SOURCE OF SELF-DIAGNOSTICS

All respondents

Figure 24: Use of self-diagnostics, by type of test, by age, October 2007

Pregnancy tests

Figure 25: Usage of single or multiple brands of pregnancy tests, October 2007

Figure 26: Usage of pregnancy tests, by age, May 2006-June 2007

Preferred pregnancy test brands

Figure 27: Brand of pregnancy tests used, May 2006-June 2007

Preferred locations for purchases of self-diagnostics

Figure 28: Preferred locations for purchases of self-diagnostic kits, by gender, October 2007

Figure 29: Preferred locations for purchases of self-diagnostic kits, by age, October 2007

Figure 30: Preferred locations for purchases of self-diagnostic kits, by household income, October 2007

Use of self-diagnostics by racial/ethnic group

Figure 31: Use of self-diagnostics, by race/ethnicity, October 2007

Pregnancy test usage among racial/ethnic groups

Figure 32: Usage of pregnancy tests, by race/ethnicity, May 2006-June 2007

Preferred locations for purchases of self-diagnostics by racial/ethnic group

Figure 33: Preferred locations for purchases of self-diagnostic kits, by race/ethnicity, October 2007

ATTITUDES TOWARDS SELF-DIAGNOSTICS/INSURANCE COVERAGE

All respondents

Figure 34: Attitudes towards selected self-diagnostics, October 2007

Primary factors in deciding which self-diagnostic kit to buy

Figure 35: Primary factors in deciding which self-diagnostic kit to buy, by gender, October 2007

Figure 36: Primary factors in deciding which self-diagnostic kit to buy, by age, October 2007

Figure 37: Primary factors in deciding which self-diagnostic kit to buy, by household income, October 2007

Insurance coverage of diabetes testing kits

Figure 38: Percentage of diabetes testing kit covered by insurance, by age, October 2007

Ethnic/racial attitudes towards self-diagnostics

Figure 39: Attitudes towards self-diagnostics, by race/ethnicity, October 2007

Primary factors in deciding which self-diagnostic kit to buy among racial/ethnic groups

Figure 40: Primary factors in deciding which self-diagnostic kit to buy, by race/ethnicity, October 2007

MARKET FORECAST

Self diagnostics market

Figure 41: Forecast of total U.S. retail sales of home diagnostics, at current and constant prices, 2007-12

Glucose monitors

Figure 42: Forecast of U.S. sales of glucose monitors, at current and constant prices, 2007-12

Pregnancy tests

Figure 43: Forecast of U.S. sales of pregnancy tests, at current and constant prices, 2007-12

Blood pressure monitors

Figure 44: Forecast of U.S. sales of blood pressure monitors, at current and constant prices, 2007-12

Ovulation tests

Figure 45: Forecast of U.S. sales of ovulation tests, at current and constant prices, 2007-12

Forecast factors

APPENDIX: TRADE ASSOCIATIONS